BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30951184)

  • 1. Immunological response in horses following West Nile virus vaccination with inactivated or recombinant vaccine.
    Monaco F; Purpari G; Di Gennaro A; Mira F; Di Marco P; Guercio A; Savini G
    Vet Ital; 2019 Mar; 55(1):73-79. PubMed ID: 30951184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
    Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
    Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.
    Fehér O; Bakonyi T; Barna M; Nagy A; Takács M; Szenci O; Joó K; Sárdi S; Korbacska-Kutasi O
    Vet Immunol Immunopathol; 2020 Sep; 227():110087. PubMed ID: 32629300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
    Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
    Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.
    Khatibzadeh SM; Gold CB; Keggan AE; Perkins GA; Glaser AL; Dubovi EJ; Wagner B
    Am J Vet Res; 2015 Jan; 76(1):92-100. PubMed ID: 25535666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
    Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG
    Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
    Kitai Y; Kondo T; Konishi E
    J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
    Minke JM; Siger L; Karaca K; Austgen L; Gordy P; Bowen R; Renshaw RW; Loosmore S; Audonnet JC; Nordgren B
    Arch Virol Suppl; 2004; (18):221-30. PubMed ID: 15119777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
    Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA
    Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
    Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis).
    Wolf TM; Gandolf AR; Dooley JL; Atkinson MW; Wolfe BA
    J Zoo Wildl Med; 2008 Dec; 39(4):537-41. PubMed ID: 19110693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine vaccine for West Nile virus.
    Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
    Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
    Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
    Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of horses from West Nile virus Lineage 2 challenge following immunization with a whole, inactivated WNV lineage 1 vaccine.
    Bowen RA; Bosco-Lauth A; Syvrud K; Thomas A; Meinert TR; Ludlow DR; Cook C; Salt J; Ons E
    Vaccine; 2014 Sep; 32(42):5455-9. PubMed ID: 25131745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring Anti-NS1 Antibodies in West Nile Virus-Infected and Vaccinated Horses.
    Rebollo B; Sarraseca J; Lecollinet S; Abouchoaib N; Alonso J; García-Bocanegra I; Sanz AJ; Venteo Á; Jiménez-Clavero MA
    Biomed Res Int; 2018; 2018():8309816. PubMed ID: 30356362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.
    Siger L; Bowen RA; Karaca K; Murray MJ; Gordy PW; Loosmore SM; Audonnet JC; Nordgren RM; Minke JM
    Am J Vet Res; 2004 Nov; 65(11):1459-62. PubMed ID: 15566080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic responses to West Nile virus in vaccinated and clinically affected horses.
    Davidson AH; Traub-Dargatz JL; Rodeheaver RM; Ostlund EN; Pedersen DD; Moorhead RG; Stricklin JB; Dewell RD; Roach SD; Long RE; Albers SJ; Callan RJ; Salman MD
    J Am Vet Med Assoc; 2005 Jan; 226(2):240-5. PubMed ID: 15706975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.